RAFAEL HOLDINGS, INC. Current State and Local Tax Expense (Benefit)
RAFAEL HOLDINGS, INC. (RFL) reported Current State and Local Tax Expense (Benefit) of -$2.39 million for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for the quarter ending 2021-07-31 was -$27.00M.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for the quarter ending 2021-04-30 was $2.40M.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for the quarter ending 2021-01-31 was $9.30M.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for the quarter ending 2020-10-31 was $15.30M.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2025 was -$2.39M.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2024 was -$2.60M.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2023 was -$274.00K.
- RAFAEL HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2021 was $1.00K.
| Period end | Current State and Local Tax Expense (Benefit) 3 month | Current State and Local Tax Expense (Benefit) 6 month | Current State and Local Tax Expense (Benefit) 9 month | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-07-31 | -$2.39M 10-K · filed 2025-10-29 | |||
| 2024-07-31 | -$2.60M 10-K · filed 2025-10-29 | |||
| 2023-07-31 | -$274.00K 10-K/A · filed 2024-12-20 | |||
| 2021-07-31 | -$27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$24.60M derived: sum of 2 quarters · filed 2022-10-31 | -$15.30M derived: sum of 3 quarters · filed 2022-10-31 | $1.00K 10-K · filed 2022-10-31 |
| 2021-04-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | $11.70M derived: sum of 2 quarters · filed 2021-06-14 | $27.00M 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | $24.60M 10-Q · filed 2021-03-17 | ||
| 2020-10-31 | $15.30M 10-Q · filed 2020-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |